Literature DB >> 24464492

Induction of multipotency in umbilical cord-derived mesenchymal stem cells cultivated under suspension conditions.

Fatemeh Amiri1, Raheleh Halabian, Morteza Salimian, Mohammad Ali Shokrgozar, Masoud Soleimani, Ali Jahanian-Najafabadi, Mehryar Habibi Roudkenar.   

Abstract

Due to the limitations in the clinical application of embryonic stem cells (ESC) and induced pluripotent stem cells, mesenchymal stem cells (MSCs) are now much more interesting for cell-based therapy. Although MSCs have several advantages, they are not capable of differentiating to all three embryonic layers (three germ layers) without cultivation under specific induction media. Hence, improvement of MSCs for cell therapy purposes is under intensive study now. In this study, we isolated MSCs from umbilical cord tissue at the single-cell level, by treatment with trypsin, followed by cultivation under suspension conditions to form a colony. These colonies were trypsin resistant, capable of self-renewal differentiation to the three germ layers without any induction, and they were somewhat similar to ESC colonies. The cells were able to grow in both adherent and suspension culture conditions, expressed both the MSCs markers, especially CD105, and the multipotency markers, i.e., SSEA-3, and had a limited lifespan. The cells were expanded under simple culture conditions at the single-cell level and were homogenous. Further and complementary studies are required to understand how trypsin-tolerant mesenchymal stem cells are established. However, our study suggested non-embryonic resources for future cell-based therapy.

Mesh:

Substances:

Year:  2014        PMID: 24464492      PMCID: PMC4147073          DOI: 10.1007/s12192-014-0491-x

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  36 in total

1.  Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.

Authors:  Lu-Lu Lu; Yong-Jun Liu; Shao-Guang Yang; Qin-Jun Zhao; Xin Wang; Wei Gong; Zhi-Bo Han; Zhen-Shu Xu; Yong-Xin Lu; Delong Liu; Zhi-Zhe Chen; Zhong-Chao Han
Journal:  Haematologica       Date:  2006-07-25       Impact factor: 9.941

Review 2.  Cross-border research on human embryonic stem cells: legal and ethical considerations.

Authors:  Heidi Mertes; Guido Pennings
Journal:  Stem Cell Rev Rep       Date:  2008-12-04       Impact factor: 5.739

3.  [Study on culture and in vitro osteogenesis of blood-derived human mesenchymal stem cells].

Authors:  Cong Cao; Yinghai Dong; Yuqi Dong
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2005-08

4.  Suspension cultures of bone-marrow-derived mesenchymal stem cells: effects of donor age and glucose level.

Authors:  Alexandra Stolzing; Eva Bauer; Andrew Scutt
Journal:  Stem Cells Dev       Date:  2012-06-01       Impact factor: 3.272

5.  Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells.

Authors:  Chui-Yee Fong; Li-Ling Chak; Arijit Biswas; Jee-Hian Tan; Kalamegam Gauthaman; Woon-Khiong Chan; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 6.  Wharton's jelly-derived cells are a primitive stromal cell population.

Authors:  Deryl L Troyer; Mark L Weiss
Journal:  Stem Cells       Date:  2007-12-06       Impact factor: 6.277

7.  Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells.

Authors:  Ying-Nan Zhang; Pu-Chang Lie; Xing Wei
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

8.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

Authors:  Ralf Hass; Cornelia Kasper; Stefanie Böhm; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2011-05-14       Impact factor: 5.712

Review 9.  Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine.

Authors:  Paul S Knoepfler
Journal:  Stem Cells       Date:  2009-05       Impact factor: 6.277

Review 10.  Why are MSCs therapeutic? New data: new insight.

Authors:  A I Caplan
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

View more
  6 in total

Review 1.  In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability.

Authors:  Fatemeh Amiri; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2014-12-20       Impact factor: 3.667

2.  Co-culture of mesenchymal stem cell spheres with hematopoietic stem cells under hypoxia: a cost-effective method to maintain self-renewal and homing marker expression.

Authors:  Fatemeh Amiri; Ali Asghar Kiani; Marzie Bahadori; Mehryar Habibi Roudkenar
Journal:  Mol Biol Rep       Date:  2021-11-06       Impact factor: 2.316

3.  Quantitative Analysis of SSEA3+ Cells from Human Umbilical Cord after Magnetic Sorting.

Authors:  Zikuan Leng; Dongming Sun; Zihao Huang; Iman Tadmori; Ning Chiang; Nikhit Kethidi; Ahmed Sabra; Yoshihiro Kushida; Yu-Show Fu; Mari Dezawa; Xijing He; Wise Young
Journal:  Cell Transplant       Date:  2019-04-18       Impact factor: 4.064

Review 4.  The mechanisms of mutual relationship between malignant hematologic cells and mesenchymal stem cells: Does it contradict the nursing role of mesenchymal stem cells?

Authors:  Alireza Goodarzi; Mohsen Valikhani; Fatemeh Amiri; Armita Safari
Journal:  Cell Commun Signal       Date:  2022-03-02       Impact factor: 5.712

Review 5.  Plumping up a Cushion of Human Biowaste in Regenerative Medicine: Novel Insights into a State-of-the-Art Reserve Arsenal.

Authors:  Nima Najafi-Ghalehlou; Alireza Feizkhah; Mohammadreza Mobayen; Zahra Pourmohammadi-Bejarpasi; Shima Shekarchi; Amaneh Mohammadi Roushandeh; Mehryar Habibi Roudkenar
Journal:  Stem Cell Rev Rep       Date:  2022-05-03       Impact factor: 6.692

6.  Combination Therapy of Metadichol Nanogel and Lipocalin-2 Engineered Mesenchymal Stem Cells Improve Wound Healing in Rat Model of Excision Injury.

Authors:  Zahra Pourmohammadi-Bejarpasi; Reza Sabzevari; Amaneh Mohammadi Roushandeh; Ammar Ebrahimi; Mohammadreza Mobayen; Ali Jahanian-Najafabadi; Abbas Darjani; Mehryar Habibi Roudkenar
Journal:  Adv Pharm Bull       Date:  2021-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.